replicant
Premiership Player
But should a substance be OK if it has approval from say Nicaragua ( no offence to Nicaragua ) which may have a looser regulatory system.
And some countries approve substances, and other countries ban the same substance. This doesn't necessarily lead to an even playing field. And there be an element of confusion.
This is why I doubt the long term application of SO.
To get approval in Nicaragua, it would need to complete clinical trials. Thus any PED or negative side effects would be known.
Despite the threat of "looser regulatory requirements", the company developing the drug in question would leave themselves open to a world of law suits if they didn't properly complete the tests or if an unknown side effect turns up. Medical product testing would be no less rigorous in Nicaragua than it is anywhere else thanks to the fact the drug industry is international.
WADA can't test every drug. They rely on clinical trials to identify PED properties, and whether a drug should be banned. Until clinical trials are complete, in any jurisdiction, they can't fully assess anything.
That's why i have no doubt S0 will keep applying, and with the modern prevalence of designer drugs, will become more important, not less.




